← FDA ENFORCEMENT
D-0208-2025Class III
Appco Pharma LLC
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Appco Pharma LLC
Product type
Drug
Status
Completed
Report date
2025-01-29
Distribution
Nationwide USA.
Firm state
NJ
Product quantity
1380 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Product description
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Code / lot info
Lot #: 2402101UR, Exp 02/28/2027
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →